CIDP Patient Perspectives on IG Treatment
A research team is looking for participants for a market research study on treatments for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). If you currently receive immunoglobulin (or Ig) therapy for CIDP, you might be a good fit for this study. Help others with CIDP by participating in this important research.
- 60-minute phone interview to be scheduled at a convenient time
- Computer or laptop needed – video conferencing software will be used to show materials
- If you qualify and complete the interview, you will receive $125 in compensation
- The research is confidential – your personal information will not be shared
- Complete a short screener to see if you qualify using this link: Click Here
Contact Vincent.Tagliareni@SchlesingerGroup.com with any questions